Chris MacDonald

Chris MacDonald

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

PTGX Stock: Why Protagonist Therapeutics Is Plunging 60% Today

Today, investors in Protagonist Therapeutics and PTGX stock have seen an absolutely massive decline due to an FDA hold of its clinical trial.

HLBZ Stock: What to Know as Little-Known Helbiz Rockets Higher

Today, investors watching Helbiz and HLBZ stock are seeing absolutely incredible triple-digit gains as volume soars for this small-cap.

Horizen Price Predictions: How High Can a Coinbase Listing Take the ZEN Crypto?

Today, investors are increasingly becoming interested in what the expert Horizen price predictions are as news around this crypto swirls.

AABB Stock Fans Are Waiting for Big Crypto Exchange News

Here's what investors may want to know about the shift Asia Broadband is making that could take AABB stock on a nice ride.

LCID Stock Revs Up on Record-Setting Nod From the EPA

Here's what investors interested in Lucid Motors and LCID stock should note today, as the company made an impressive EPA rating announcement.